19-43511448-T-C
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_014297.5(ETHE1):c.494A>G(p.Asp165Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000229 in 1,614,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D165H) has been classified as Uncertain significance.
Frequency
Consequence
NM_014297.5 missense
Scores
Clinical Significance
Conservation
Publications
- ethylmalonic encephalopathyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ETHE1 | NM_014297.5 | c.494A>G | p.Asp165Gly | missense_variant | Exon 4 of 7 | ENST00000292147.7 | NP_055112.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251466 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461878Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 727236 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74346 show subpopulations
ClinVar
Submissions by phenotype
Ethylmalonic encephalopathy Pathogenic:4
This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 165 of the ETHE1 protein (p.Asp165Gly). This variant is present in population databases (rs756235299, gnomAD 0.002%). This missense change has been observed in individual(s) with ethylmalonic encephalopathy (PMID: 21472225). ClinVar contains an entry for this variant (Variation ID: 435094). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ETHE1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects ETHE1 function (PMID: 31477743). This variant disrupts the p.Asp165 amino acid residue in ETHE1. Other variant(s) that disrupt this residue have been observed in individuals with ETHE1-related conditions (PMID: 21472225, 32111695), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
- -
- -
- -
not provided Pathogenic:1
The D165G variant in the ETHE1 gene has previously been reported as homozygous in an individual with ethylmalonic encephalopathy (Walsh et al., 2010). The D165G variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The D165G variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (R163W, R163Q, T164K) have been reported in the Human Gene Mutation Database in association with ethylmalonic encephalopathy (Stenson et al., 2014), supporting the functional importance of this region of the protein. In summary, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at